Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS SUMMARY: UK Inflation Slips Back To Zero In June

Tue, 14th Jul 2015 10:22

LONDON (Alliance News) - The following is a summary of top news stories Tuesday.
----------
COMPANIES
----------
AstraZeneca said the US Food and Drug Administration has approved Iressa (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer whose tumors harbor specific types of epidermal growth factor receptor gene mutations, as detected by an FDA-approved test.
----------
International Public Partnerships said the Bazalgette Consortium, of which it is a part, has been named preferred bidder for the GBP4.2 billion Thames Tideway Tunnel Project in London. The infrastructure investment company said it will invest GBP210 million in the project, with the rest of the risk capital to be funded by the other partners in the consortium.
----------
FTSE 250-listed property developer Derwent London said it has agreed revised terms on its collaboration arrangement with Crossrail on the 1 Oxford Street development in central London. The initial agreement to develop the site above the Tottenham Court Road London Underground station was signed in 2007, with Derwent surrendering its existing holdings in 2009 as the start of the construction of Crossrail began. The revised agreement outlines the terms whereby Derwent will once more own the key interest in the redevelopment, it said.
----------
Dairy Crest Group said its Cheese and Spreads businesses have performed in line with company expectations during the first quarter of its financial year and said its outlook for the full year remains unchanged. Dairy Crest said that it expects sales in its key brands to perform strongly as the year progresses, although it repeated that the combined performance of the Cheese and Spreads businesses will be weighted towards the second half. Dairy Crest is holding its annual general meeting later on Tuesday.
----------
Business information publisher Euromoney Institutional Investor said it has struck a deal to acquire a 10% stake in financial estimates platform Estimize for USD3.6 million in cash. The purchase of the stake was made as part of a USD6 million Series B funding found for Estimize. The company sources estimates from hedge fund, brokerage and independent analysts to provide consensus market expectations. As part of the investment, Euromoney's BCA Research business will partner with Estimize on building new datasets.
----------
Recruitment company Michael Page International said the weak euro is continuing to drag on its gross profit, even as it posted a rise for the first half of the year, sending shares in the company lower in morning trade. Michael Page said its gross profit in the first half to the end of June was up by 6.6%, though it rose by 10.8% in constant currencies. The greatest currency translation drag for the company came in its Europe, Middle East and Africa business, where its reported gross profit rose by only 1.6%, but was up by 11.8% in constant currencies in the half.
----------
Construction and facilities management company Carillion said it performed in line with its expectations in the first half of 2015 and said its forecasts for the full year remain unchanged. Carillion added its order book and pipeline of opportunities remain strong, despite the impact the UK General Election had on public sector contract awards made in the first half. Carillion also said it has won a GBP80 million contract with BP to build the operational base and accommodation complex for the Khazzan gas project in Oman.
----------
Public transport company FirstGroup said it traded in line with its expectations in the first quarter of its current financial year, with continued growth in its UK rail business, but some more challenging conditions seen in its other units. FirstGroup said it continued to see strong passenger revenue growth in its UK rail business in the quarter to the end of June, but said its UK bus arm has seen continued commercial passenger revenue growth offset by concessionary revenue, though it is making progress on its cost efficiency programme in the latter business. Elsewhere, the group said its Greyhound business in the US is still facing challenges from cheaper fuel, which is pushing people to use their own cars rather than coach services.
----------
MARKETS
----------
UK stocks are trading lower as crude oil prices take a hit after Iran and foreign ministers from six major world powers reached a comprehensive agreement to alleviate concerns over Tehran's controversial nuclear programme, lifting sanctions on the major oil producer in return.
----------
FTSE 100: down 0.3% at 6,715.18
FTSE 250: down 0.4% at 17,638.41
AIM ALL-SHARE: down 0.1% at 751.97
----------
The pound is up against the dollar, as Bank of England Governor Mark Carney provides an outlook on interest rates before the UK Treasury Select Committee.
----------
GBP: up at USD1.5550
EUR: up at USD1.1027

GOLD: down at USD1153.67 per ounce
OIL (Brent): down at USD56.77 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Foreign ministers from six world powers and Iran reached a long-awaited agreement to prevent the Islamic republic from developing nuclear weapons following a final marathon round of talks in Vienna. "It is a decision that can open a new chapter in international relations," said EU chief diplomat Federica Mogherini, who chaired the group of the US, Britain, France, Germany, Russia and China in the talks with Iran. "This is a sign of hope for the whole world," she added.
----------
Greek Prime Minister Alexis Tsipras faced a showdown with members of his SYRIZA party angered by his capitulation to European demands for the most sweeping austerity package in the history of the common currency. Tsipras' coalition is in disarray over a preliminary deal brokered in Brussels that keeps the beleaguered Greek economy in the eurozone but bypasses many of the campaign pledges on which SYRIZA swept to power. A meeting of party members began Tuesday morning to assess hurdles to parliamentary ratification of the deal, as labour unions and political factions promised strikes and demonstrations in protest of renewed austerity measures. Before formal negotiations can begin on up to EUR86 billion in bailout funds, the Greek parliament must agree to legislate on a raft of measures that are even tougher than those rejected by more than 61% of Greeks in a July 5 referendum.
----------
UK inflation returned to zero in June, data published by the Office for National Statistics showed. Consumer prices remained flat on a yearly basis in June as expected by economists after rising 0.1% in May. The consumer price index remained unchanged on a monthly basis in contrast to a 0.2% increase in May and a 0.1% rise forecast by economists. Core inflation that excludes energy, food, alcoholic beverages and tobacco, eased marginally to 0.8% in June from 0.9% in May. Factory gate prices continued its downward trend in June. Output prices decreased 1.5% year-on-year in June following a 1.6% drop in May. Prices were expected to fall 1.4%.
----------
The total value of like-for-like sales in the UK was up 1.8% on year in June, the British Retail Consortium said. That topped forecasts for an increase of 0.5% following the flat reading in May. Overall sales were up 2.9% on year, the BRC said. "We saw welcome signs of growing consumer confidence, with people more willing to 'trade-up' and spend a bit more on big-ticket purchases, likely boosted by the growth in the supply of credit and other factors such as low inflation and rising real incomes," BRC Director General Helen Dickinson said.
----------
UK Prime Minister David Cameron is set to outline his plan to close the gender pay gap in the UK, including requiring companies in the UK to publish the difference between the average pay of their male and female employees. Cameron will say that the new National Living Wage, announced in the Summer Budget last week, will primarily help women, who tend to be in lower paid jobs and will aid his push to close the gender pay gap. All British companies with more than 250 employees will have to publish the difference in pay for their male and female employees.
----------
Eurozone industrial production declined unexpectedly in May largely due to a fall in energy output, data from Eurostat showed. Industrial production was down 0.4% month-on-month in May after staying flat in April. It was forecast to rise 0.2% in May. However, annual growth in industrial output accelerated to 1.6% from 0.9% a month ago. But it was slower than a 2% rise forecast by economists.
----------
Germany's inflation slowed as initially estimated in June due to falling energy prices, final data from Destatis showed. Inflation eased to 0.3% in June from 0.7% in May. The inflation rate as measured by the consumer price index decreased after four months of uninterrupted increase.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.